These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9397226)

  • 1. Epoprostenol in the treatment of congestive heart failure.
    Phillips BB; Gandhi AJ
    Am J Health Syst Pharm; 1997 Nov; 54(22):2613-5. PubMed ID: 9397226
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of prostacyclin and its analogues in the treatment of cardiovascular disease.
    Fink AN; Frishman WH; Azizad M; Agarwal Y
    Heart Dis; 1999; 1(1):29-40. PubMed ID: 11720602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin and risk of thromboembolism.
    Varela-Aguilar JM; Sánchez-Hueso MC; González-Jimenez MD; García-Contreras RF; González dela Puente MA
    Eur Heart J; 1997 Feb; 18(2):349. PubMed ID: 9043854
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomes.
    O'Connor CM; Gattis WA; Zannad F; McNulty SE; Gheorghiade M; Adams KF; Califf RM; McKenna WJ; Soler-Soler J; Swedberg K
    Eur J Heart Fail; 1999 Mar; 1(1):81-8. PubMed ID: 10937984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute effects of prostaglandin I2 analogue (OP-41483, alpha-CD) on the disturbances of pulmonary circulation with right ventricular failure].
    Araki Y; Hanamoto S; Koh M; Kawabata S; Kimura K; Obata Y; Sawada M
    Kokyu To Junkan; 1988 Feb; 36(2):179-83. PubMed ID: 3291034
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of the economic evaluation of the first study. A multinational prospective economic evaluation. FIRST Investigators. Flolan International Randomized Survival Trial.
    Schulman KA; Buxton M; Glick H; Sculpher M; Guzman G; Kong J; Backhouse M; Mauskopf J; Bell L; Eisenberg JM
    Int J Technol Assess Health Care; 1996; 12(4):698-713. PubMed ID: 9136477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
    Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
    J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous epoprostenol for primary pulmonary hypertension.
    Higenbottam T
    N Engl J Med; 1996 May; 334(22):1477; author reply 1477-8. PubMed ID: 8618595
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary pulmonary hypertension: new treatment options].
    Madan S; Boonstra A; Berger RM
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1836-42. PubMed ID: 11593786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous epoprostenol for primary pulmonary hypertension.
    Schulze-Neick I; Lange PE; Haas NA
    N Engl J Med; 1996 May; 334(22):1477; author reply 1477-8. PubMed ID: 8618596
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of prostaglandins and kinin-kallikrein system in heart failure].
    Yui Y; Kawai C
    Nihon Rinsho; 1983 Dec; 41(12):2735-9. PubMed ID: 6325759
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostacyclin: basic principles and clinical application in congestive heart failure and primary pulmonary hypertension. Proceedings of a symposium. Bologna, Italy, November 20, 1993.
    Am J Cardiol; 1995 Jan; 75(3):1A-73A. PubMed ID: 7840048
    [No Abstract]   [Full Text] [Related]  

  • 13. Single coronary artery with the absence of a left anterior descending artery.
    Wasson S; Tejwani L; Angampally R; Flaker G
    J Invasive Cardiol; 2005 Nov; 17(11):E20-3. PubMed ID: 16264210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PGI2 therapy in congestive heart failure and its effects on the sympathetic nervous activity].
    Yui Y; Nakajima H; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1983 Jan; 31(1):59-61. PubMed ID: 6344169
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of prostacyclin in patients with continuous hemofiltration after open heart surgery.
    Klotz KF; Gellersen H; Brzelinski T; Sedemund-Adib B; Gehring H
    Contrib Nephrol; 1995; 116():136-9. PubMed ID: 8529366
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostacyclin--its function and indications for therapeutic use].
    Ram R; Levy Y; Shoenfeld Y
    Harefuah; 2000 Jan; 138(1):54-8. PubMed ID: 10868182
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous epoprostenol for treatment-refractory reversible cerebral vasoconstriction syndrome (RCVS).
    Thydén AL; Muhamad AA; Jacobsen A; Kondziella D
    J Neurol Sci; 2016 May; 364():56-8. PubMed ID: 27084217
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of OP-41483.alpha-CD, a prostacyclin analog, in the treatment of congestive refractory heart failure--efficacy as a vasodilator].
    Moriuchi M; Saito S; Tamura Y; Honye J; Ando T; Kaseda N; Tsuji M; Yumikura S; Hibiya K; Ozawa Y
    Kokyu To Junkan; 1986 Feb; 34(2):195-200. PubMed ID: 3518002
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
    Reddy MT; Patel H; Ventura HO
    Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma.
    St-Pierre P; Deschamps A; Cartier R; Basmadjian AJ; Denault AY
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):723-9. PubMed ID: 23623891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.